Chris Wagner

Chris Wagner

Vorstandsvorsitzender bei
Immunoflex Therapeutics, Inc.
57 Jahre
Health Technology
Consumer Services
Industrial Services

Profil

Chris Wagner was the founder of Canexia Health, Inc. (Canada), founded in 2012, where the title held was Chief Executive Officer.
Mr. Wagner is also the founder of Aspreva Pharmaceuticals Corp.,Immunoflex Therapeutics, Inc...
Mr. Wagner currently holds the position of Director at Contextual Health since 2019.
Mr. Wagner also serves as Area Manager-New Mexico at Meridian Engineering Co. Former positions include President & Chief Executive Officer at Sirius Genomics, Inc., Director at Emerald Health Therapeutics, Inc. from 2018 to 2019, Independent Director at Filament Health Corp.
from 2021 to 2024, and Principal at Eli Lilly & Co. Education includes undergraduate studies at the University of British Columbia.

Aktive Positionen von Chris Wagner

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 01.05.2019
Corporate Officer/Principal -
Immunoflex Therapeutics, Inc.
Vorstandsvorsitzender -

Ehemalige bekannte Positionen von Chris Wagner

UnternehmenPositionEnde
FILAMENT HEALTH CORP. Direktor/Vorstandsmitglied 01.04.2024
EMERALD HEALTH THERAPEUTICS Vorstandsvorsitzender 28.11.2018
Vorstandsvorsitzender -
Gründer -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Chris Wagner im Detail an

Ausbildung von Chris Wagner

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

8

Beziehungen ersten Grades

10

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen10

Health Technology

Health Technology

Consumer Services

Health Technology

Industrial Services

Process Industries

Health Technology

Health Technology

Immunoflex Therapeutics, Inc.

Health Services

  1. Börse
  2. Insiders
  3. Chris Wagner